Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC [Phase 2]
Phase 2 trial update of neoadjuvant MPDL3280A (atezolizumab) with nab-paclitaxel and carboplatin in non-small cell lung cancer has completed…
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating neoadjuvant PD-1 antibody plus apatinib or chemotherapy for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma [Phase 1]
Phase 1 trial assessing trigriluzole in combination with nivolumab and pembrolizumab for various metastatic or unresectable solid tumors and…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab [Phase 1, Phase 2]
Phase 1/2 trial of CD40 agonist APX005M (sotigalimab) with nivolumab in cancer including metastatic non-small cell lung cancer and melanoma …
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity [Phase 2]
Phase 2 trial update exploring afatinib response and resistance in intratumour heterogeneity for non-small cell lung cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment Failure [Phase 3]
A Phase 3 trial evaluating sintilimab with IBI305 plus pemetrexed and cisplatin for EGFR-mutant, locally advanced or metastatic non-squamous…
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation [Phase 1, Phase 2]
A study investigating RC48-ADC in combination with Pyrotinib for locally advanced or metastatic non-small cell lung cancer with HER2 mutatio…
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating QL1706 in combination with chemotherapy for advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Study Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients [Phase 3]
Phase 3 trial comparing WX-0593 to crizotinib in ALK-positive non-small cell lung cancer is underway, status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating a targeted ALK therapy in ALK-positive non-squamous non-small cell lung cancer patients who have been previously …
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: MRD Guiding Treatment After Almonertinib Induction Therapy for EGFRm+ Stage III NSCLC in the MDT Diagnostic Model. [Phase 3]
Phase 3 clinical trial investigating MRD-guided treatment after almonertinib induction therapy for EGFRm+ stage III non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab [Phase 1, Phase 2]
A dose-escalation and confirmation study of PT-112 combined with avelumab was conducted in advanced solid tumors, including non-small cell l…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]
Early-stage clinical trial update evaluating Oncorine (H101) with tislelizumab and chemotherapy in untreated advanced non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases [Phase 2]
Phase 2 trial exploring cadonilimab with bevacizumab and chemotherapy for advanced non-squamous non-small cell lung cancer with untreated br…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial update for HBI-8000 in combination with nivolumab across melanoma, renal cell carcinoma, and non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities [Phase 2]
Phase 2 clinical trial update for sotorasib in advanced KRASG12C-mutated non-small cell lung cancer patients with comorbidities.
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing utidelone to docetaxel in locally advanced or metastatic non-small cell lung cancer is underway, with status curre…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy [Phase 2]
Phase 2 trial investigating ipatasertib with docetaxel in metastatic non-small cell lung cancer after failure of first-line immunotherapy.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update comparing HB1801 to Taxotere in locally advanced or metastatic non-small cell lung cancer; status is currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents [Phase 1, Phase 2]
Phase 1/2 trial evaluating OR2805, a anti-CD163 monoclonal antibody, alone and with anticancer agents for solid tumors, with unspecified sta…
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy [Phase 3]
A Phase 3 trial evaluating HS-10241 in combination with almonertinib is comparing it to platinum-based chemotherapy in advanced non-small ce…
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating chemoradiation plus durvalumab, followed by surgery and adjuvant durvalumab, in surgically resectable Stage III (N2…
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: A Study of Local Envafolimab Injection Combined With Chemotherapy in Non-small Cell Lung Cancer [Phase 2]
Phase 2 study investigating local Envafolimab injection combined with chemotherapy for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update testing sotatercept for chemotherapy-induced anemia in patients with advanced non-small cell lung cancer. The study was…
-
CLINICAL_TRIALS trial_result · 2023-10-30Clinical Trial Update: An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer [Phase 2]
Open-label Phase 2 trial results for encorafenib plus binimetinib in BRAFV600-mutant non-small cell lung cancer have been completed and post…